 | • レポートコード：MRC308GR11604 • 出版社/出版日：GlobalInfoResearch / 2023年8月12日 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のバソプレシン拮抗薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のバソプレシン拮抗薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– バソプレシン拮抗薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
バソプレシン拮抗薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・ヴァプリゾール、トルバプタン
用途別セグメント
・中枢性尿崩症、腎性尿崩症、その他
主要な市場プレーヤー
・Otsuka、Cumberland Pharmaceuticals、Mayo Clinic、Hopital du Sacre-Coeur de Montreal
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、バソプレシン拮抗薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なバソプレシン拮抗薬メーカーの企業概要、2019年～2022年までのバソプレシン拮抗薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なバソプレシン拮抗薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別バソプレシン拮抗薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのバソプレシン拮抗薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのバソプレシン拮抗薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびバソプレシン拮抗薬の産業チェーンを掲載しています。
・第14、15章では、バソプレシン拮抗薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– バソプレシン拮抗薬の概要
– 種類別分析（2018年vs2022年vs2029年）：ヴァプリゾール、トルバプタン
– 用途別分析（2018年vs2022年vs2029年）：中枢性尿崩症、腎性尿崩症、その他
– 世界のバソプレシン拮抗薬市場規模・予測
– 世界のバソプレシン拮抗薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Otsuka、Cumberland Pharmaceuticals、Mayo Clinic、Hopital du Sacre-Coeur de Montreal
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：ヴァプリゾール、トルバプタン
・用途別分析2018年-2029年：中枢性尿崩症、腎性尿崩症、その他
・バソプレシン拮抗薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・バソプレシン拮抗薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・バソプレシン拮抗薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・バソプレシン拮抗薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・バソプレシン拮抗薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Vasopressin Antagonist
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Vasopressin Antagonist Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Vaprisol
1.3.3 Tolvaptan
1.4 Market Analysis by Application
1.4.1 Overview: Global Vasopressin Antagonist Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Central Diabetes Insipidus
1.4.3 Nephrogenic Diabetes Insipidus
1.4.4 Other
1.5 Global Vasopressin Antagonist Market Size & Forecast
1.5.1 Global Vasopressin Antagonist Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Vasopressin Antagonist Sales Quantity (2018-2029)
1.5.3 Global Vasopressin Antagonist Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Otsuka
2.1.1 Otsuka Details
2.1.2 Otsuka Major Business
2.1.3 Otsuka Vasopressin Antagonist Product and Services
2.1.4 Otsuka Vasopressin Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Otsuka Recent Developments/Updates
2.2 Cumberland Pharmaceuticals
2.2.1 Cumberland Pharmaceuticals Details
2.2.2 Cumberland Pharmaceuticals Major Business
2.2.3 Cumberland Pharmaceuticals Vasopressin Antagonist Product and Services
2.2.4 Cumberland Pharmaceuticals Vasopressin Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Cumberland Pharmaceuticals Recent Developments/Updates
2.3 Mayo Clinic
2.3.1 Mayo Clinic Details
2.3.2 Mayo Clinic Major Business
2.3.3 Mayo Clinic Vasopressin Antagonist Product and Services
2.3.4 Mayo Clinic Vasopressin Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Mayo Clinic Recent Developments/Updates
2.4 Hopital du Sacre-Coeur de Montreal
2.4.1 Hopital du Sacre-Coeur de Montreal Details
2.4.2 Hopital du Sacre-Coeur de Montreal Major Business
2.4.3 Hopital du Sacre-Coeur de Montreal Vasopressin Antagonist Product and Services
2.4.4 Hopital du Sacre-Coeur de Montreal Vasopressin Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Hopital du Sacre-Coeur de Montreal Recent Developments/Updates
3 Competitive Environment: Vasopressin Antagonist by Manufacturer
3.1 Global Vasopressin Antagonist Sales Quantity by Manufacturer (2018-2023)
3.2 Global Vasopressin Antagonist Revenue by Manufacturer (2018-2023)
3.3 Global Vasopressin Antagonist Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Vasopressin Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Vasopressin Antagonist Manufacturer Market Share in 2022
3.4.2 Top 6 Vasopressin Antagonist Manufacturer Market Share in 2022
3.5 Vasopressin Antagonist Market: Overall Company Footprint Analysis
3.5.1 Vasopressin Antagonist Market: Region Footprint
3.5.2 Vasopressin Antagonist Market: Company Product Type Footprint
3.5.3 Vasopressin Antagonist Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Vasopressin Antagonist Market Size by Region
4.1.1 Global Vasopressin Antagonist Sales Quantity by Region (2018-2029)
4.1.2 Global Vasopressin Antagonist Consumption Value by Region (2018-2029)
4.1.3 Global Vasopressin Antagonist Average Price by Region (2018-2029)
4.2 North America Vasopressin Antagonist Consumption Value (2018-2029)
4.3 Europe Vasopressin Antagonist Consumption Value (2018-2029)
4.4 Asia-Pacific Vasopressin Antagonist Consumption Value (2018-2029)
4.5 South America Vasopressin Antagonist Consumption Value (2018-2029)
4.6 Middle East and Africa Vasopressin Antagonist Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Vasopressin Antagonist Sales Quantity by Type (2018-2029)
5.2 Global Vasopressin Antagonist Consumption Value by Type (2018-2029)
5.3 Global Vasopressin Antagonist Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Vasopressin Antagonist Sales Quantity by Application (2018-2029)
6.2 Global Vasopressin Antagonist Consumption Value by Application (2018-2029)
6.3 Global Vasopressin Antagonist Average Price by Application (2018-2029)
7 North America
7.1 North America Vasopressin Antagonist Sales Quantity by Type (2018-2029)
7.2 North America Vasopressin Antagonist Sales Quantity by Application (2018-2029)
7.3 North America Vasopressin Antagonist Market Size by Country
7.3.1 North America Vasopressin Antagonist Sales Quantity by Country (2018-2029)
7.3.2 North America Vasopressin Antagonist Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Vasopressin Antagonist Sales Quantity by Type (2018-2029)
8.2 Europe Vasopressin Antagonist Sales Quantity by Application (2018-2029)
8.3 Europe Vasopressin Antagonist Market Size by Country
8.3.1 Europe Vasopressin Antagonist Sales Quantity by Country (2018-2029)
8.3.2 Europe Vasopressin Antagonist Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Vasopressin Antagonist Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Vasopressin Antagonist Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Vasopressin Antagonist Market Size by Region
9.3.1 Asia-Pacific Vasopressin Antagonist Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Vasopressin Antagonist Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Vasopressin Antagonist Sales Quantity by Type (2018-2029)
10.2 South America Vasopressin Antagonist Sales Quantity by Application (2018-2029)
10.3 South America Vasopressin Antagonist Market Size by Country
10.3.1 South America Vasopressin Antagonist Sales Quantity by Country (2018-2029)
10.3.2 South America Vasopressin Antagonist Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Vasopressin Antagonist Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Vasopressin Antagonist Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Vasopressin Antagonist Market Size by Country
11.3.1 Middle East & Africa Vasopressin Antagonist Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Vasopressin Antagonist Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Vasopressin Antagonist Market Drivers
12.2 Vasopressin Antagonist Market Restraints
12.3 Vasopressin Antagonist Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Vasopressin Antagonist and Key Manufacturers
13.2 Manufacturing Costs Percentage of Vasopressin Antagonist
13.3 Vasopressin Antagonist Production Process
13.4 Vasopressin Antagonist Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Vasopressin Antagonist Typical Distributors
14.3 Vasopressin Antagonist Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Vasopressin Antagonist Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Vasopressin Antagonist Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Otsuka Basic Information, Manufacturing Base and Competitors
Table 4. Otsuka Major Business
Table 5. Otsuka Vasopressin Antagonist Product and Services
Table 6. Otsuka Vasopressin Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Otsuka Recent Developments/Updates
Table 8. Cumberland Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Cumberland Pharmaceuticals Major Business
Table 10. Cumberland Pharmaceuticals Vasopressin Antagonist Product and Services
Table 11. Cumberland Pharmaceuticals Vasopressin Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Cumberland Pharmaceuticals Recent Developments/Updates
Table 13. Mayo Clinic Basic Information, Manufacturing Base and Competitors
Table 14. Mayo Clinic Major Business
Table 15. Mayo Clinic Vasopressin Antagonist Product and Services
Table 16. Mayo Clinic Vasopressin Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Mayo Clinic Recent Developments/Updates
Table 18. Hopital du Sacre-Coeur de Montreal Basic Information, Manufacturing Base and Competitors
Table 19. Hopital du Sacre-Coeur de Montreal Major Business
Table 20. Hopital du Sacre-Coeur de Montreal Vasopressin Antagonist Product and Services
Table 21. Hopital du Sacre-Coeur de Montreal Vasopressin Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Hopital du Sacre-Coeur de Montreal Recent Developments/Updates
Table 23. Global Vasopressin Antagonist Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 24. Global Vasopressin Antagonist Revenue by Manufacturer (2018-2023) & (USD Million)
Table 25. Global Vasopressin Antagonist Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 26. Market Position of Manufacturers in Vasopressin Antagonist, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 27. Head Office and Vasopressin Antagonist Production Site of Key Manufacturer
Table 28. Vasopressin Antagonist Market: Company Product Type Footprint
Table 29. Vasopressin Antagonist Market: Company Product Application Footprint
Table 30. Vasopressin Antagonist New Market Entrants and Barriers to Market Entry
Table 31. Vasopressin Antagonist Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Vasopressin Antagonist Sales Quantity by Region (2018-2023) & (K Units)
Table 33. Global Vasopressin Antagonist Sales Quantity by Region (2024-2029) & (K Units)
Table 34. Global Vasopressin Antagonist Consumption Value by Region (2018-2023) & (USD Million)
Table 35. Global Vasopressin Antagonist Consumption Value by Region (2024-2029) & (USD Million)
Table 36. Global Vasopressin Antagonist Average Price by Region (2018-2023) & (US$/Unit)
Table 37. Global Vasopressin Antagonist Average Price by Region (2024-2029) & (US$/Unit)
Table 38. Global Vasopressin Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 39. Global Vasopressin Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 40. Global Vasopressin Antagonist Consumption Value by Type (2018-2023) & (USD Million)
Table 41. Global Vasopressin Antagonist Consumption Value by Type (2024-2029) & (USD Million)
Table 42. Global Vasopressin Antagonist Average Price by Type (2018-2023) & (US$/Unit)
Table 43. Global Vasopressin Antagonist Average Price by Type (2024-2029) & (US$/Unit)
Table 44. Global Vasopressin Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 45. Global Vasopressin Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 46. Global Vasopressin Antagonist Consumption Value by Application (2018-2023) & (USD Million)
Table 47. Global Vasopressin Antagonist Consumption Value by Application (2024-2029) & (USD Million)
Table 48. Global Vasopressin Antagonist Average Price by Application (2018-2023) & (US$/Unit)
Table 49. Global Vasopressin Antagonist Average Price by Application (2024-2029) & (US$/Unit)
Table 50. North America Vasopressin Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Vasopressin Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 52. North America Vasopressin Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 53. North America Vasopressin Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 54. North America Vasopressin Antagonist Sales Quantity by Country (2018-2023) & (K Units)
Table 55. North America Vasopressin Antagonist Sales Quantity by Country (2024-2029) & (K Units)
Table 56. North America Vasopressin Antagonist Consumption Value by Country (2018-2023) & (USD Million)
Table 57. North America Vasopressin Antagonist Consumption Value by Country (2024-2029) & (USD Million)
Table 58. Europe Vasopressin Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Europe Vasopressin Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Europe Vasopressin Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 61. Europe Vasopressin Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 62. Europe Vasopressin Antagonist Sales Quantity by Country (2018-2023) & (K Units)
Table 63. Europe Vasopressin Antagonist Sales Quantity by Country (2024-2029) & (K Units)
Table 64. Europe Vasopressin Antagonist Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Vasopressin Antagonist Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Vasopressin Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Asia-Pacific Vasopressin Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 68. Asia-Pacific Vasopressin Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Asia-Pacific Vasopressin Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 70. Asia-Pacific Vasopressin Antagonist Sales Quantity by Region (2018-2023) & (K Units)
Table 71. Asia-Pacific Vasopressin Antagonist Sales Quantity by Region (2024-2029) & (K Units)
Table 72. Asia-Pacific Vasopressin Antagonist Consumption Value by Region (2018-2023) & (USD Million)
Table 73. Asia-Pacific Vasopressin Antagonist Consumption Value by Region (2024-2029) & (USD Million)
Table 74. South America Vasopressin Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 75. South America Vasopressin Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 76. South America Vasopressin Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 77. South America Vasopressin Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 78. South America Vasopressin Antagonist Sales Quantity by Country (2018-2023) & (K Units)
Table 79. South America Vasopressin Antagonist Sales Quantity by Country (2024-2029) & (K Units)
Table 80. South America Vasopressin Antagonist Consumption Value by Country (2018-2023) & (USD Million)
Table 81. South America Vasopressin Antagonist Consumption Value by Country (2024-2029) & (USD Million)
Table 82. Middle East & Africa Vasopressin Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 83. Middle East & Africa Vasopressin Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 84. Middle East & Africa Vasopressin Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Middle East & Africa Vasopressin Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Middle East & Africa Vasopressin Antagonist Sales Quantity by Region (2018-2023) & (K Units)
Table 87. Middle East & Africa Vasopressin Antagonist Sales Quantity by Region (2024-2029) & (K Units)
Table 88. Middle East & Africa Vasopressin Antagonist Consumption Value by Region (2018-2023) & (USD Million)
Table 89. Middle East & Africa Vasopressin Antagonist Consumption Value by Region (2024-2029) & (USD Million)
Table 90. Vasopressin Antagonist Raw Material
Table 91. Key Manufacturers of Vasopressin Antagonist Raw Materials
Table 92. Vasopressin Antagonist Typical Distributors
Table 93. Vasopressin Antagonist Typical Customers
List of Figures
Figure 1. Vasopressin Antagonist Picture
Figure 2. Global Vasopressin Antagonist Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Vasopressin Antagonist Consumption Value Market Share by Type in 2022
Figure 4. Vaprisol Examples
Figure 5. Tolvaptan Examples
Figure 6. Global Vasopressin Antagonist Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Vasopressin Antagonist Consumption Value Market Share by Application in 2022
Figure 8. Central Diabetes Insipidus Examples
Figure 9. Nephrogenic Diabetes Insipidus Examples
Figure 10. Other Examples
Figure 11. Global Vasopressin Antagonist Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Vasopressin Antagonist Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Vasopressin Antagonist Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Vasopressin Antagonist Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Vasopressin Antagonist Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Vasopressin Antagonist Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Vasopressin Antagonist by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Vasopressin Antagonist Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Vasopressin Antagonist Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Vasopressin Antagonist Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Vasopressin Antagonist Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Vasopressin Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Vasopressin Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Vasopressin Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Vasopressin Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Vasopressin Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Vasopressin Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Vasopressin Antagonist Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Vasopressin Antagonist Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Vasopressin Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Vasopressin Antagonist Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Vasopressin Antagonist Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Vasopressin Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Vasopressin Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Vasopressin Antagonist Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Vasopressin Antagonist Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Vasopressin Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Vasopressin Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Vasopressin Antagonist Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Vasopressin Antagonist Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Vasopressin Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Vasopressin Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Vasopressin Antagonist Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Vasopressin Antagonist Consumption Value Market Share by Region (2018-2029)
Figure 53. China Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Vasopressin Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Vasopressin Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Vasopressin Antagonist Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Vasopressin Antagonist Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Vasopressin Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Vasopressin Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Vasopressin Antagonist Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Vasopressin Antagonist Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Vasopressin Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Vasopressin Antagonist Market Drivers
Figure 74. Vasopressin Antagonist Market Restraints
Figure 75. Vasopressin Antagonist Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Vasopressin Antagonist in 2022
Figure 78. Manufacturing Process Analysis of Vasopressin Antagonist
Figure 79. Vasopressin Antagonist Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source